karppaus.infon arkistoitu foorumi

Tänään on 2026-06-26 09:39:47

Kaikki ajat ovat UTC+02:00




Aloita uusi ketju  Vastaa viestiin  [ 1 viesti ] 
Julkaisija Viesti
ViestiLähetetty: 2023-12-23 14:53:17 
Poissa
ruutana
ruutana

Liittynyt: 2007-05-25 15:55:11
Viestit: 29698
Kuva
https://cardiab.biomedcentral.com/artic ... 23-02090-1

Lainaa:
Published: 19 December 2023

Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis

Cardiovascular Diabetology volume 22, Article number: 350 (2023)

Abstract
Background
Elevated glycated hemoglobin (HbA1c) is associated with a higher burden of subclinical atherosclerosis (SA). However, the association with SA of earlier insulin resistance markers is poorly understood. The study assessed the association between the homeostatic model assessment of insulin resistance index (HOMA-IR) and SA in addition to the effect of cardiovascular risk factors (CVRFs) in individuals with normal HbA1c.

Methods
A cohort of 3,741 middle-aged individuals from the Progression of Early Subclinical Atherosclerosis (PESA) study with basal HbA1c < 6.0% (< 42 mmol/mol) and no known CV disease underwent extensive imaging (multiterritorial vascular ultrasound and coronary artery calcium score, CACS) to assess the presence, burden, and extent of SA.

Results
Individuals with higher HOMA-IR values had higher rates of CVRFs. HOMA-IR showed a direct association with the multiterritorial extent of SA and CACS (p < 0.001) and with global plaque volume measured by 3-dimensional vascular ultrasound (p < 0.001). After adjusting for key CVRFs and HbA1c, HOMA-IR values ≥ 3 were associated with both the multiterritorial extent of SA (odds ratio 1.41; 95%CI: 1.01 to 1.95, p = 0.041) and CACS > 0 (odds ratio 1.74; 95%CI: 1.20 to 2.54, p = 0.004), as compared with the HOMA-IR < 2 (the reference HOMA-IR category). In a stratified analysis, this association remained significant in individuals with a low-to-moderate SCORE2 risk estimate (75.6% of the cohort) but not in high-risk individuals.

Conclusions
The use of HOMA-IR identified low-risk individuals with a higher burden of SA, after adjusting for the effects of key traditional CVRFs and HbA1c. HOMA-IR is a simple measure that could facilitate earlier implementation of primary CV prevention strategies in clinical practice.


Ylös
   
Näytä viestit ajalta:  Järjestä  
Aloita uusi ketju  Vastaa viestiin  [ 1 viesti ] 

Kaikki ajat ovat UTC+02:00


Paikallaolijat

Käyttäjiä lukemassa tätä aluetta: Ei rekisteröityneitä käyttäjiä ja 19 vierailijaa


Et voi kirjoittaa uusia viestejä
Et voi vastata viestiketjuihin
Et voi muokata omia viestejäsi
Et voi poistaa omia viestejäsi
Et voi lähettää liitetiedostoja

Etsi tätä:
Hyppää:  
Keskustelufoorumin ohjelmisto phpBB® Forum Software © phpBB Limited
Käännös: phpBB Suomi (lurttinen, harritapio, Pettis)